Maternal Pertussis Generic Advice

ATAGI endorsed generic advice on maternal pertussis vaccination that was developed following the pertussis Industry briefing in June 2015. The advice will be available to any interested vaccine manufacturers on request, and may be used as generic presubmission advice for sponsors wishing to pursue a PBAC submission for maternal pertussis vaccination.

Read more

  United Kingdom
JCVI interim statement on adult pneumococcal vaccination

During 2015 the Joint Committee on Vaccination and Immunisation (JCVI) and its pneumococcal sub-committee have reviewed the adult pneumococcal vaccination programme. This interim position statement outlines JCVI’s considerations. The committee will consult stakeholders before producing a final statement.

Read more

Vaccination against pertussis: aims and strategy

Current vaccination policy, with the first jab around the age of two months, leaves the youngest infants unprotected against pertussis (whooping cough). Young infants, however, are most vulnerable for the diseases and can even die of it. According to the Health Council of the Netherlands, antibodies from the mother can offer effective and safe protection. To this end pregnant women should be offered vaccination against pertussis in the 3rd trimester of pregnancy.

Read more

Advice on the relevance of implementing a vaccine against whopping cough for all pregnant women in Quebec

TheNITAG of Quebec does not have sufficient evidence to recommend the vaccination of all pregnant women in Quebec against whopping cough. This recommendation should be revised within the next two years in light of new data available on the innocuity profile, the possible interference with primovaccination, the acceptability, the feasibility, and the cost effectiveness associated with this particular strategy. 

Read more

Focus on

No countries left behind in SEAR where all 11 countries have a NITAG

With the establishment of a NITAG in Timor-Leste in November 2015, active NITAGs now exist in all 11 SEAR countries. The technical capacity at a national level is being enhanced by supporting NITAGs to monitor immunization coverage and providing advocacy on further strengthening of national immunization programmes through evidence-based decisionmaking. SEARO is preparing a document to share the experience and lessons learnt on the formation of NITAGs in SEAR.
Read more
Scientific resource
Influenza vaccination policy-making processes in France and The Netherlands

Health Policy / January 2016

The authors investigate key differences in the French and Dutch policy-making processes for the development of vaccination recommendations. This paper presents preliminary results on the evidence used in the decision-making process and focuses on the interactions between the experts and stakeholders, focusing more specifically on NITAGs.

Read more

Scientific resource
Gavi’s Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs

Health Affairs / February 2016

This article discusses some of the challenges facing countries currently transitioning out of Gavi support, how Gavi’s policies have evolved to help manage the risks involved in this process, and the lessons learned from this experience.

Read more

Operational resource
Evaluating National Immunization Technical Advisory Groups (NITAGs)
HPID Center / January 2016

This tool provides you with guidance and templates to:
  • Prepare your evaluation
  • Collect data through various sources
  • Analyze information and write the evaluation report

Read more

Operational resource
WHO Position Paper on Malaria Vaccine
WHO / January 2016

This is the first WHO position paper on a malaria vaccine. It focuses primarily on the available evidence concerning the only candidate malaria vaccine to have received a positive regulatory assessment, which was issued by the European Medicines Agency (EMA) in July 2015.

Read more

Gayane Sahakyan
Executive Secretary
Armenian NITAG
Development of evidence-based recommendations has always been a challenge for the Armenian NITAG due to the limited availability of information. 
Read more
  Upcoming events  
7 - 8
  Regional NITAG Consultation

A 2-day consultation with the SEAR NITAG Chairs and Secretariats to define the terms of reference of the regional network and to strengthen capacity in NITAG operating processes and evidence-based decision making, which were identified by participants at the ITAG side-meeting as priority topics.

Organized by WHO SEARO & HPID Center
Colombo, Sri Lanka
Read more
12 - 14
  SAGE meeting

Discover what the agenda (as of February 15th) has to offer...

Organized by WHO
Read more
28 - 29
  Nordic Vaccine Meeting

Various aspects of vaccination will be tackled including Asylum seekers (health evaluation and vaccination); NITAGs in the North of Europe, HPV vaccines, Impact of childhood pneumococcal vaccination in the Nordic Countries and the relevance of Hepatitis B vaccination for nordic countries.

Organized by Athygli Conferences
Reykjavik, Iceland
Read more
11 - 12
  Annual meeting of the international NITAG network

All NITAG chairs  and a representative from their secretariats from around the world are kindly invited to discuss collaboration around NITAG evaluation 

Organized by the HPID Center & WHO
Veryier du lac
  Previous events  
  ACIP meeting

The ACIP reviewed several post-approval studies of meningococcal serogroup B vaccine  to further evaluate the vaccine’s safety and efficacy profile.  Additionally, the Committee was presented with data from a mass immunization campaign that occurred in response to a large meningococcal serogroup B outbreak in Quebec, Canada.  There was also discussion pertaining to a possible increased risk of meningococcal disease among HIV infected persons. Other topics included HPV, flu, Japanese Encephalitis...

Organized by US-CDC
1600 Clifton Road, Atlanta
Read more
Copyright © 2016 Nitag Resource Center
Unsubscribe from this list - Change subscription preferences